Comparative photodynamic therapy cytotoxicity of mannose-conjugated chlorin and talaporfin sodium in cultured human and rat cells

Journal of Toxicological Sciences

Volumn 42, Issue 1, 2017, Pages 111-119

  Shinoda, Yo ^a   Takahashi, Tsutomu ^a   Akimoto, Jiro ^b   Ichikawa, Megumi ^b   Yamazaki, Hiromi ^c   Narumi, Atsushi ^c   Yano, Shigenobu ^d   Fujiwara, Yasuyuki ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Malignant brain tumor; Photodynamic therapy (PDT); Photosensitizer; Talaporfin sodium (NPe6); Mannose conjugated chlorin ( M chlorin)

Indexed keywords

BETA MANNOSE CONJUGATED CHLORIN; PHOTOSENSITIZING AGENT; TALAPORFIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CHLORIN; MANNOSE; PORPHYRIN;

ANIMAL CELL; ARTICLE; BRAIN CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY ASSAY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; EMBRYO; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; NONHUMAN; PC12 CELL LINE; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PUP (RODENT); RAT; RAT EMBRYO; ANIMAL; CELL CULTURE; CELL LINE; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; LIGHT; METABOLISM; NERVE CELL; PHOTOCHEMOTHERAPY; RADIATION RESPONSE; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; HUMANS; LIGHT; MANNOSE; NEURONS; PC12 CELLS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, WISTAR;

EID: 85009376659     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.42.111     Document Type: Article

References (30)

1. Colombeau, L., Acherar, S., Baros, F., Arnoux, P., Gazzali, A.M., Zaghdoudi, K., Toussaint, M., Vanderesse, R. and Frochot, C. (2016): Inorganic Nanoparticles for Photodynamic Therapy. Top. Curr. Chem., 370, 113-134.
2. Devarajan, P.V. and Jain, S. (2015): Targeted Drug Delivery: Concepts and Design. Springer International Publishing.
3. Dolmans, D.E., Fukumura, D. and Jain, R.K. (2003): Photodynamic therapy for cancer. Nat. Rev. Cancer, 3, 380-387.
4. Dougherty, T.J., Gomer, C.J., Henderson, B.W., Jori, G., Kessel, D., Korbelik, M., Moan, J. and Peng, Q. (1998): Photodynamic therapy. J. Natl. Cancer Inst., 90, 889-905.
5. Hayashi, N., Kataoka, H., Yano, S., Tanaka, M., Moriwaki, K., Akashi, H., Suzuki, S., Mori, Y., Kubota, E., Tanida, S., Takahashi, S. and Joh, T. (2015): A novel photodynamic therapy targeting cancer cells and tumor-associated macrophages. Mol. Cancer Ther., 14, 452-460.
6. Horimatsu, T., Muto, M., Yoda, Y., Yano, T., Ezoe, Y., Miyamoto, S. and Chiba, T. (2012): Tissue damage in the canine normal esophagus by photoactivation with talaporfin sodium (laserphyrin): a preclinical study. PLoS One, 7, e38308.
7. Hsieh, Y.J., Wu, C.C., Chang, C.J. and Yu, J.S. (2003): Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J. Cell. Physiol., 194, 363-375.
8. Jori, G. (1996): Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J. Photochem. Photobiol. B, 36, 87-93.
9. Juarranz, A., Jaén, P., Sanz-Rodríguez, F., Cuevas, J. and González, S. (2008): Photodynamic therapy of cancer. Basic principles and applications. Clin. Transl. Oncol., 10, 148-154.
10. Kessel, D., Luo, Y., Deng, Y. and Chang, C.K. (1997): The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem. Photobiol., 65, 422-426.
11. Leung, W.N., Sun, X., Mak, N.K. and Yow, C.M. (2002): Photodynamic effects of mTHPC on human colon adenocarcinoma cells: photocytotoxicity, subcellular localization and apoptosis. Photochem. Photobiol., 75, 406-411.
12. Lilly, J.D. and Parsons, C.L. (1990): Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg. Gynecol. Obstet., 171, 493-496.
13. MacDonald, I.J., Morgan, J., Bellnier, D.A., Paszkiewicz, G.M., Whitaker, J.E., Litchfield, D.J. and Dougherty, T.J. (1999): Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives. Photochem. Photobiol., 70, 789-797.
14. Manyak, M.J., Smith, P.D., Harrington, F.S., Steinberg, S.M., Glatstein, E. and Russo, A. (1988): Protection against dihematoporphyrin ether photosensitivity. Photochem. Photobiol., 47, 823-830.
15. Mehraban, N. and Freeman, H.S. (2015): Developments in PDT Sensitizers for Increased Selectivity and Singlet Oxygen Production. Materials, 8, 4421-4456.
16. Miki, Y., Akimoto, J., Hiranuma, M. and Fujiwara, Y. (2014): Effect of talaporfin sodium-mediated photodynamic therapy on cell death modalities in human glioblastoma T98G cells. J. Toxicol. Sci., 39, 821-827.
17. Nakajima, Y., Iguchi, H., Kamisuki, S., Sugawara, F., Furuichi, T. and Shinoda, Y. (2016): Low doses of the mycotoxin citrinin protect cortical neurons against glutamate-induced excitotoxicity. J. Toxicol. Sci., 41, 311-319.
18. Narumi, A., Tsuji, T., Shinohara, K., Yamazaki, H., Kikuchi, M., Kawaguchi, S., Mae, T., Ikeda, A., Sakai, Y., Kataoka, H., Inoue, M., Nomoto, A., Kikuchi, J. and Yano, S. (2016): Maltotrioseconjugation to a fluorinated chlorin derivative generating a PDT photosensitizer with improved water-solubility. Org. Biomol. Chem., 14, 3608-3613.
19. Nelson, J.S., Roberts, W.G. and Berns, M.W. (1987): In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy. Cancer Res., 47, 4681-4685.
20. O’Connor, A.E., Gallagher, W.M. and Byrne, A.T. (2009): Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem. Photobiol., 85, 1053-1074.
21. Peng, Q., Moan, J. and Nesland, J.M. (1996): Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct. Pathol., 20, 109-129.
22. Reiners, J.J., Jr., Caruso, J.A., Mathieu, P., Chelladurai, B., Yin, X.M. and Kessel, D. (2002): Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ., 9, 934-944.
23. Savoia, P., Deboli, T., Previgliano, A. and Broganelli, P. (2015): Usefulness of Photodynamic Therapy as a Possible Therapeutic Alternative in the Treatment of Basal Cell Carcinoma. Int. J. Mol. Sci., 16, 23300-23317.
24. Schinkel, A.H. (1999): P-Glycoprotein, a gatekeeper in the bloodbrain barrier. Adv Drug Deliv Rev, 36, 179-194.
25. Sears, B. and Perry, M. (2015): The role of fatty acids in insulin resistance. Lipids Health Dis., 14, 121.
26. Senge, M.O. (2012): mTHPC--a drug on its way from second to third generation photosensitizer? Photodiagnosis Photodyn. Ther., 9, 170-179.
27. Shan, L. (2004): Protoporphyrin IX and IR-820 fluorophore-encapsulated organically modified silica nanoparticles. In: Molecular Imaging and Contrast Agent Database (MICAD), Bethesda (MD).
28. Sibata, C.H., Colussi, V.C., Oleinick, N.L. and Kinsella, T.J. (2000): Photodynamic therapy: a new concept in medical treatment. Braz. J. Med. Biol. Res., 33, 869-880.
29. Triesscheijn, M., Baas, P., Schellens, J.H. and Stewart, F.A. (2006): Photodynamic therapy in oncology. Oncologist, 11, 1034-1044.
30. Ziemys, A., Yokoi, K. and Kojic, M. (2015): Capillary collagen as the physical transport barrier in drug delivery to tumor microenvironment. Tissue Barriers, 3, e1037418.